 |
|
Drug Pipeline
Regenesance BV is producing a robust pipeline of compounds that inhibit the complement pathway at various intervention points. Certain compounds show efficacy in selected animal models and appear to be well tolerated.
|
|
|
|
About Us
Regenesance BV was founded in November, 2009 on ground breaking research from the Academic Medical Center (AMC) at the University of Amsterdam in the Netherlands.
|
|
|
|
Latest News
View latest press releases below
in pdf format.
14 October 2011
Regenesance Receives Innovation Credit from Dutch Government.
Visit our Media Center page for more news. |
|
|